glp-1 microdosing research GLP-1s like Ozempic: the trend a doctor wants you to understand first Microdosing GLP-1s: How (and Why)

In April, a paper in BMC Ophthalmology identified patterns of eye problems among people who took oral or injectable semaglutide

The glucose-dependent insulinotropic polypeptide (GIP), another gastrointestinal hormone, plays a similar role to the GLP-1 hormone, and GIP receptors are another target for weight-loss drugs

Several are now underway including the REMODEL T1D trial (semaglutide and kidney disease in T1D) and the SURPASS-T1D phase 3 trials (tirzepatide in T1D) with results expected in the coming years

Leslie Gammon, 54, an office manager from Wendell, North Carolina, said she turned to a telehealth company called Amble Health for a weight loss drug prescription

There are Ozempic: Ozempic is a medication prescribed to decrease blood sugar in people with type 2 diabetes